Vue PACS Diagnostic Viewer with Vue PACS client 12.1.5 to 12.2.8.454 software Model Number: 1149418 Intended use is t... — FDA record Z-0497-2025

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 10, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Vue PACS Diagnostic Viewer with Vue PACS client 12.1.5 to 12.2.8.454 software Model Number: 1149418 Intended use is to provide completely scalable local and wide area PACS (Picture Archiving and Communication System) solutions for hospital and related institutions/sites.
Reason
A software issue affecting Philips Vue PACS may cause incorrect ischemic map and table value calculations when using the export function in the Perfusion Application for a Siemens CT perfusion study, resulting in misdiagnosis due to incorrect ischemic map and table values.
Classification
Class II
Recalling firm
Philips Medical Systems Technologies Ltd.
Quantity
2439 systems
Agency-reported status
Ongoing
Source record identifier
Z-0497-2025

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI: (01)00884838100350(11)200221(10)12.2.5; (01)00884838100350(11)200812(10)12.2.6.0; (01)00884838100350(11)201207(10)12.2.6.100; (01)00884838100350(11)210303(10)12.2.6.200; (01)00884838100350(11)210518(10)12.2.6.201; (01)00884838100350(11)210729(10)12.2.6.300; (01)00884838100350(11)210502(10)12.2.8.0; (01)00884838100350(11)220112(10)12.2.8.100; (01)00884838100350(11)221213(10)12.2.8.200; (01)00884838100350(11)230301(10)12.2.8.210; (01)00884838100350(11)230320(10)12.2.8.300; (01)00884838100350(11)230608(10)12.2.8.310; (01)00884838100350(11)230718(10)12.2.8.400; (01)00884838100350(11)230810(10)12.2.8.401; (01)00884838100350(11)230824(10)12.2.8.317; (01)00884838100350(11)231019(10)12.2.8.412; (01)00884838100350(11)231108(10)12.2.8.403; (01)00884838100350(11)231129(10)12.2.8.413; (01)00884838100350(11)231214(10)12.2.8.414; (01)00884838100350(11)231204(10)12.2.8.420; (01)00884838100350(11)240101(10)12.2.8.415; (01)00884838100350(11)240116(10)12.2.8.421; (01)00884838100350(11)240204(10)12.2.8.422; (01)00884838100350(11)240226(10)12.2.8.424; (01)00884838100350(11)240311(10)12.2.8.426; (01)00884838100350(11)240407(10)12.2.8.440; (01)00884838100350(11)240425(10)12.2.8.450; (01)00884838100350(11)240613(10)12.2.8.451; (01)00884838100350(11)240715(10)12.2.8.452; (01)00884838100350(11)240715(10)12.2.8.454; (01)00884838100350(11)230926(10)12.2.8.410

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide and Worldwide Distribution Foreign: Country Argentina Australia Austria Belgium Brazil Chile China Colombia Denmark Finland France Germany Gibraltar Greece Guernsey Holy See (Vatican City State) Hong Kong Hungary Indonesia Ireland Israel Italy Japan Jersey Jordan Lebanon Malaysia Mexico Netherlands New Zealand Norway Oman Panama Philippines Poland Portugal Romania Saudi Arabia Serbia Slovenia Spain Sweden Switzerland Taiwan Thailand United Kingdom

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Nov 27, 2024
Recall initiation date
Oct 10, 2024
Center classification date
Nov 20, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records